Company intelligence / Profile preview

Bathera

Ownership: Private
Development stage: Other

Overview

Bathera produces and distributes high-quality medical cannabis products in Europe. The company has pioneered in-house genetics research for premium cannabis strains. Their products are commercially available and include high-potency THC flower.

No clinical trial data or traditional pharmaceutical development results are reported.

Therapeutic areas: NeurologyOther
Modalities: Cannabis-based therapy (Medical cannabis flower and derivatives)
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Bathera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bathera.

Explore the full profile